Ogorek Anthony Joseph’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.79M Sell
8,159
-1,552
-16% -$1.59M 2.43% 13
2026
Q1
$8.93M Sell
9,711
-2,373
-20% -$2.41M 2.45% 13
2025
Q4
$13M Sell
12,084
-371
-3% -$355K 3.57% 10
2025
Q3
$9.5M Buy
12,455
+1,109
+10% +$825K 2.72% 14
2025
Q2
$8.85M Buy
11,346
+2
+0% +$1.55K 2.73% 14
2025
Q1
$9.37M Buy
11,344
+53
+0.5% +$44.1K 3.08% 10
2024
Q4
$8.72M Buy
11,291
+127
+1% +$105K 2.77% 10
2024
Q3
$9.89M Buy
11,164
+18
+0.2% +$16.2K 3.39% 9
2024
Q2
$10.1M Sell
11,146
-24
-0.2% -$19.2K 3.51% 9
2024
Q1
$8.69M Sell
11,170
-127
-1% -$90.4K 3.02% 9
2023
Q4
$6.58M Sell
11,297
-25
-0.2% -$14.6K 2.39% 12
2023
Q3
$6.08M Sell
11,322
-80
-0.7% -$41.2K 2.4% 15
2023
Q2
$5.35M Buy
11,402
+160
+1% +$67.1K 2.05% 15
2023
Q1
$3.86M Buy
11,242
+249
+2% +$84K 1.58% 19
2022
Q4
$4.02M Sell
10,993
-72
-0.7% -$25.5K 1.75% 16
2022
Q3
$3.58M Buy
11,065
+58
+0.5% +$18.4K 1.7% 15
2022
Q2
$3.57M Buy
11,007
+250
+2% +$75K 1.64% 14
2022
Q1
$3.08M Buy
10,757
+3,258
+43% +$838K 1.26% 20
2021
Q4
$2.07M Buy
7,499
+7,349
+4,899% +$1.86M 0.88% 22
2021
Q3
$34K Hold
150
0.02% 92
2021
Q2
$34K Hold
150
0.02% 90
2021
Q1
$28K Hold
150
0.01% 92
2020
Q4
$25K Hold
150
0.01% 83
2020
Q3
$22K Buy
+150
New +$23.2K 0.01% 75

Other funds holding LLY

Ogorek Anthony Joseph's LLY Position: Q2 2026 in Review

Ogorek Anthony Joseph reduced its Eli Lilly (LLY) stake by 16% in Q2 2026, selling an estimated $1.59M and leaving 8,159 shares worth $9.79M. The position accounts for 2.43% of the portfolio, ranked #13.

Ogorek Anthony Joseph first reported a position in LLY in Q3 2020 and has held it in 24 quarters since. The position peaked at $13M in Q4 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ogorek Anthony Joseph held 8,159 shares of Eli Lilly worth $9.79M as of Q2 2026.
  • Ogorek Anthony Joseph sold 1,552 Eli Lilly shares in Q2 2026, an estimated $1.59M.
  • Eli Lilly made up 2.43% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #13 holding.
  • Ogorek Anthony Joseph first reported a position in Eli Lilly in Q3 2020 and has held it in 24 quarters since.
  • Ogorek Anthony Joseph's Eli Lilly position peaked at $13M in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.